DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Align Technology

XRAY vs. ALGN: Which Stock Is the Better Value Option?

CHARLOTTE, N.C., April 07, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), today announced that the Company will host an investor conference call and live webcast on Thursday, May 6, 2021 at 8:30 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.

Dentsply Sirona to Host First Quarter 2021 Conference Call on May 6th

Dentsply (XRAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Surging Earnings Estimates Signal Upside for Dentsply (XRAY) Stock

Investor confidence is high in the DENTSPLY SIRONA (XRAY) stock, thanks to solid prospects.

Why You Should Add DENTSPLY SIRONA (XRAY) to Your Portfolio

As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA (XRAY).

DENTSPLY SIRONA's (XRAY) Shares March Higher, Can It Continue?

DENTSPLY SIRONA (XRAY) is optimistic about growth in CAD/CAM business arm along with its recent product launch and strategic buyouts.

DENTSPLY SIRONA (XRAY) at a 52-Week High: What's Driving It?

The stock price of Dentsply Sirona, a dental equipment company, has seen a solid 13% rise over the last five trading days, but we believe the stock, after the recent rally, may trend lower in the near term. The recent rise can largely be attributed to the company's better than expected Q4 results.

Despite A Strong Q4 Dentsply Sirona Stock May See A Correction

CHARLOTTE, N.C., March 09, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced it will participate in the 2021 Barclays Global Healthcare Conference on March 10th.

Dentsply Sirona to Present at the 2021 Barclays Global Healthcare Conference on March 10th

Dentsply Sirona, Inc. (XRAY) CEO Don Casey on Q4 2020 Results - Earnings Call Transcript

Shares of Dentsply Sirona (NASDAQ:XRAY) rose 3.6% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 19.18% over the past year to $0.87, which beat the estimate of $0.64.

Dentsply Sirona: Q4 Earnings Insights

CHARLOTTE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), The Dental Solutions Company, today announced its financial results for the fourth quarter and full year 2020.

Dentsply Sirona Reports Fourth Quarter and Full Year 2020 Results

DENTSPLY (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for DENTSPLY (XRAY)

PHILADELPHIA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Dentsply Siorona Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) on behalf of the Company's stockholders.

Kaskela Law LLC Announces Investigation of Dentsply Siorona Inc. (XRAY) and Encourages Long-Term XRAY Stockholders to Contact the Firm

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dentsply International (XRAY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CHARLOTTE, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), today announced that the Company will host an investor conference call and live webcast on Monday, March 1, 2021 at 8:30 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.

Dentsply Sirona to Host Fourth Quarter and Full Year 2020 Conference Call on March 1st

Dentsply Sirona has been struggling since the merger between Dentsply and Sirona in 2015. The company has not delivered on operational improvements over time, and despite these struggles and the impact of Covid-19, the company is making another significant deal.

Dentsply Sirona: Some Concerns After Dealmaking Returns

CHARLOTTE, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced it will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th.

Dentsply Sirona to Present at the 39th Annual J.P. Morgan Healthcare Conference

DENTSPLY (XRAY) acquires Byte to strengthen presence in the lucrative clear aligner space.

DENTSPLY (XRAY) Acquires Byte to Boost Clear Aligner Business

Dentsply Sirona Inc. said Monday it has acquired Byte, a privately owned clear aligner provider, in an all-cash deal valued at $1.04 billion. Byte offers doctor-directed care to patients with mild to moderate orthodontic needs, using a network of licensed dentists and orthodontists to deliver clear aligners to straighten teeth directly to a consumer's home.

Dentsply Sirona acquires clear aligner provider Byte in all-cash deal valued at 1.04 billion

CHARLOTTE, N.C. and LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), and Byte, a rapidly growing clear aligner company, today announced that Dentsply Sirona acquired Byte in an all-cash deal for $1.04 billion. Byte holds a leadership position in the rapidly growing direct-to-consumer, doctor-directed clear aligner market. As a result of the transaction, Dentsply Sirona adds scale to its SureSmile® clear aligner business and strengthens its connection with dental professionals. With the global reach and supply chain expertise of Dentsply Sirona, and the innovative direct-to-consumer system that Byte brings, the combined company's clear aligner platform is well-positioned to drive additional growth.

Dentsply Sirona Acquires Byte®, a Leading Direct-to-Consumer, Doctor-Directed Clear Aligner Company

Colgate-Palmolive

CVS Health

GlaxoSmithKline

Henry Schein

Johnson & Johnson

Procter & Gamble

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

8 Dental Stocks If You Want to Clean Up

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

Why Is Dentsply (XRAY) Up 15.3% Since Last Earnings Report?

CHARLOTTE, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the 2020 Wolfe Research Virtual Healthcare Conference on November 19th.

Dentsply Sirona to present at the Wolfe Research Virtual Healthcare Conference on November 19

CHARLOTTE, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11th.

Dentsply Sirona to present at the Credit Suisse 29th Annual Virtual Healthcare Conference

Dentsply Sirona (XRAY) Q3 2020 Results - Earnings Call Transcript

News for DENTSPLY SIRONA Stock (XRAY)